News
Zacks Investment Research on MSN
Vertex Plunges Around 24% in Six Months: How to Play the Stock
Vertex Pharmaceuticals Incorporated VRTX stock has declined 23.6% in the past six months, mainly due to recent pipeline setbacks. In August 2025, Vertex’s phase II study on the oral formulation of ...
A research team led by geophysicists at UC San Diego's Scripps Institution of Oceanography provides an explanation for ...
A research team led by geophysicists at UC San Diego’s Scripps Institution of Oceanography provides an explanation for ...
Vertex Pharmaceuticals Incorporated just reported a robust Q2 with earnings per share of $4.52, surpassing estimates and ...
(BAC) highlights the Vertex® evaporative condenser, where peak reliability meets easy maintenance with enhanced materials, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback